Bronchopulmonary Dysplasia in the First Year: Insights Into Severity, Medication Use, and Healthcare Utilization

Documenti analoghi

• Social Determinants of Health and Healthcare Utilization in Infants With Bronchopulmonary Dysplasia
  di: Haley Urbach, et al.
  Pubblicazione: (2025)
• The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension
  di: Stephanie M. Tsoi, et al.
  Pubblicazione: (2026)
• Common Severity‐Based Definitions of Bronchopulmonary Dysplasia Are not Associated With Outpatient Morbidities
  di: Robin L. McKinney, et al.
  Pubblicazione: (2025)
• Using Positive End‐Expiratory Pressure to Predict and Quantify Tracheobronchomalacia in Grade 3 Bronchopulmonary Dysplasia
  di: Stephanie A. Adaikalam, et al.
  Pubblicazione: (2025)
• Lower Respiratory Tract Bacterial Profiles Are Associated With Respiratory Severity and Bronchopulmonary Dysplasia in Neonates
  di: Jelte Kelchtermans, et al.
  Pubblicazione: (2025)